Clinical Trial Update: CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating concurrent chemoradiotherapy followed by PD-1 inhibitor maintenance for locally advanced esophageal cancer is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Esophageal Carcinoma, Radiotherapy | Phase 3 | Status: RECRUITING